A government veterinarian vaccinates livestock in Naivasha following an outbreak of foot and mouth disease in the sub-county. The county government has banned the movement of livestock following an outbreak of the disease. [Antony Gitonga/Standard]
Kenya approves trials for genetically modified vaccines to combat livestock diseases
Rift Valley
By
Antony Gitonga
| Jul 04, 2025
The National Biosafety Authority (NBA) has approved field trials for testing Genetically Modified (GM) vaccines aimed at controlling various livestock diseases.
One of the primary diseases these vaccines are expected to address is Rift Valley Fever, which affects cattle, goats, sheep, and camels.
This approval comes amid ongoing litigations regarding the lifting of the GMO ban, which have hindered the full implementation of the authority's mandate.
According to the authority's Chairperson, Professor Jenesio Kinyamario, significant progress has been made in ensuring that GMO products are safe for human consumption.
READ MORE
New law aims to protect internal auditors, strengthen public oversight
Ruto launches Sh5.5 billion plan to revamp Voi-Taveta metre gauge railway
Why underwriting is shifting as risk grows more complex
World Bank approves Sh71 billion for Isiolo-Mandera road construction
Banks double lending target to small businesses to hit Sh326b
Contradictions in rural economies 13 years into devolved governance
Return of the bitter pill: Kenya softens IMF stance as Iran shock bites
Court clears way for Sh619 billion EABL shares sale
JKUAT to assemble 3,000 computers for digital hubs countrywide
Jubilee Holdings profit jumps 18 per cent on increased revenue
Professor Kinyamario stated, "The authority has approved field trials for testing GM vaccines for the control of Rift Valley Fever in cattle, goats, sheep, and camels."
He also mentioned that trials have been approved for other genetically modified crops, including Resistant Sweet Potatoes in Kakamega, Biofortified Cassava at Alupe in Busia County, and late blight-resistant Irish Potatoes in Molo.
Additionally, the blight-resistant Irish Potato is undergoing trials in Muguga (Kiambu County) and Njambini (Nyandarua), while drought-tolerant maize and the African Biofortified Sorghum (ABS) are being tested in Kiboko, Makueni County.
The authority has approved several genetically modified crops, such as Bt cotton, Bt maize, and virus-resistant cassava, which are now approved for environmental release and are undergoing National Performance Trials (NPT).
The Chairperson further noted that several policies and manuals have been approved, including those on labelling GMOs, Genome Editing, and the appointment of Biosafety Inspectors.
Additional manuals cover areas such as Asset Management and Liability, Risk Management, Data Protection, and ICT policy, all designed to help fulfil the authority's legal mandate.
"Despite these developments, the ongoing litigations regarding the lifting of the GMO ban continue to restrict our ability to fully implement our mandate," he added.
Earlier, the Kenya Plant Health Inspectorate Service (KEPHIS) announced the release of eight new varieties of Genetically Modified (GM) cassava for trials.
KEPHIS Managing Director, Professor Theophilus Mutui, stated that these eight varieties have successfully passed Distinctness, Uniformity, and Stability (DUS) tests, as well as National Performance Trials (NPT).
He emphasised that all new GM varieties must complete both trials before they can be approved for release and commercialisation.
"Eight GM cassava varieties have undergone DUS and NPT and are now ready for consideration for release by the National Performance Trials Committee," he concluded.
Share this story